SleepCited

Lavender essential oil on postmenopausal women with insomnia: Double-blind randomized trial.

Leandro Dos Reis Lucena, Jair Guilherme Dos Santos-Junior, Sergio Tufik, Helena Hachul
RCT Complementary therapies in medicine 2021 41 اقتباسات

تصميم الدراسة

نوع الدراسة
Randomized Controlled Trial
حجم العينة
35
المجتمع المدروس
Postmenopausal women with clinical diagnosis of insomnia
المدة
4 weeks
التدخل
Lavender essential oil on postmenopausal women with insomnia: Double-blind randomized trial. Lavandula angustifolia essential oil inhalation nightly for 29 days
المقارن
sunflower oil inhalation (placebo)
النتيجة الأولية
Sleep quality measured by Pittsburgh Sleep Quality Index (PSQI)
اتجاه التأثير
Neutral
خطر التحيز
Low

الملخص

BACKGROUND: To evaluate the effect of Lavandula angustifolia essential oil inhalation on sleep and menopausal symptoms in postmenopausal women with insomnia. PARTICIPANTS: 35 postmenopausal women with a clinical diagnosis of insomnia were included, 17 in Aroma Group (AG) and 18 in Placebo Group (PG). METHODS: In this double-blind, randomized controlled trial, PG participants inhaled sunflower oil and AG participants inhaledLavandula angustifolia essential oil, for 29 days. Both groups received sleep hygiene guidelines before the intervention and weekly follow-up during it. Evaluations were performed before and after intervention. All statistical analyses and intention-to-treat test were performed in SPSS 22. Sleep quality (Primary outcome) was measured by Pittsburgh Sleep Quality Index. Secondary outcomes were polysomnography data, severity of insomnia, anxiety and depression symptoms, and postmenopausal symptoms. RESULTS: There were no significant differences between groups after intervention in the primary outcome (P = 0.22; effect size=0.69); however, a tendency of improvement in wake after sleep onset (WASO) was observed (P = 0.07; effect size=0.81; B = 42.2). Both groups presented better sleep quality over time (AG P < 0.001; PG P = 0.011). AG participants showed a significant decrease in sleep onset latency (P = 0.001), depression levels (P = 0.025), hot flashes (P < 0.001), postmenopausal symptoms (P < 0.001) and, in polysomnography data, increased sleep efficiency (P = 0.002) compared to baseline. CONCLUSION: Although no significant differences were observed between groups, our data presented a tendency of improvement in WASO. Moreover, AG participants had enhanced overall sleep pattern, quality and sleep efficiency. Weekly follow-up and sleep hygiene instructions were essential for both groups to show improvement in almost all outcomes. CLINICAL TRIAL REGISTRATION: Brazilian Registry of Clinical Trials, www.ensaiosclinicos.gov.br, RBR-5q5t5z.

باختصار

Although no significant differences were observed between groups, the data presented a tendency of improvement in wake after sleep onset (WASO), and AG participants had enhanced overall sleep pattern, quality and sleep efficiency.

مُستخدم في مراجعات الأدلة